饮食遵守和缓解是否减少了乳患者的氧化应激?
Berat Ebik1, Ferhat Bacaksiz1, Ali Uzel1
1University of Health Sciences, Diyarbakır Gazi Yasargil Education and Research Hospital, Division of Gastroenterology - Diyarbakır, Turkey.
概括
达到乳性疾病的缓解改善了硫化-硫化的稳态,这表明氧化应激减少了. 不遵守无质饮食会加剧腹患者的炎症和氧化应激.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 病是一种自身免疫性疾病,由摄入质引发.
- 不遵守无质饮食会导致慢性炎症和氧化应激.
- 二硫化物恒温是氧化应激和炎症的标志物.
研究的目的:
- 为了研究缓解状态对乳二硫化物恒温的影响,在患有乳病的患者.
- 评估氧化应激和炎症在乳性疾病不合规性中的作用.
- 作为疾病活动的间接指标,建立二硫化物恒温.
主要方法:
- 这是一项前性,随机的,受控的研究,涉及117名乳病患者.
- 血液样本在基线和一年后收集,以测量醇和二硫化物.
- 此外,还监测了常规的乳病测试和抗组织转质氨酶IgA水平.
主要成果:
- 55.6%的患者没有缓解,而44.4%的患者实现了缓解.
- 实现缓解的患者表现出本源醇水平增加 (p=0.001) 和二硫化物水平降低 (p<0.001).
- 在进入缓解期的患者中,减少的二硫化物水平和减少的抗组织转质氨酶IgA之间观察到显著的相关性 (r=0.526;p<0.001).
结论:
- 缺乏缓解的乳性疾病与增加的氧化压力有关.
- 二硫化物稳态作为氧化应激和炎症的间接标记在乳病中.
- 达到缓解有效地降低了胆固醇患者的氧化应激.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158


